Isabel joined Astorg in 2023 and is a member of the Investment Team.
Prior to this, Isabel spent two years at Candesic, an M&A specialist strategy consultancy where she focused on healthcare & life science transactions. Before that, Isabel was a researcher with the Nuffield Department of Medicine at the University of Oxford.
Isabel holds an MSc in Integrated Immunology from the University of Oxford, and a BSc in Biomedical Sciences from Durham University.